Urinary EVs from pediatric patients with FSGS promoted STAT3 phosphorylation and mesangial cell proliferation, suggesting their role in mesangial cell proliferation through STAT3 pathway activation. This evidence concerns the gene STAT3 and focal segmental glomerulosclerosis.